Position
BRAIDWELL LP in Caris Life Sciences, Inc.
Back to the book · All holders of CAI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$71.1M$26.98 → $17.88
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 7.82M | $210.9M | — | — | — | 6.7% |
| Q1 2026 | 8.01M | $143.2M | $17.88 | −$71.1M | $3.46M | 4.8% |